These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 476705)

  • 21. [Cytoplasmic steroid hormone receptors in primary breast tumors].
    Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV; Vishniakova VV
    Vopr Onkol; 1982; 28(4):6-10. PubMed ID: 7090272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
    Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer.
    Yamashita J; Ogawa M; Yamashita S; Nomura K; Kuramoto M; Saishoji T; Shin S
    Cancer Res; 1994 Apr; 54(7):1630-3. PubMed ID: 8137271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
    Aryandono T; Harijadi ; Ghozali A
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
    Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
    Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.
    Teicher I; Tinker MA; Auguste LJ; Laufer H; Stein TA; Wise L
    Surgery; 1985 Oct; 98(4):784-91. PubMed ID: 4049250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between prognosis and hormone receptors in women with breast cancer.
    Papatestas AE; Miller SR; Pertsemlidis D; Fagerstrom R; Lesnick G; Aufses AH
    Cancer Detect Prev; 1986; 9(3-4):303-10. PubMed ID: 3742506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast conservation after induction chemotherapy for locally advanced breast cancer.
    Kling KM; Ostrzega N; Schmit P
    Am Surg; 1997 Oct; 63(10):861-4. PubMed ID: 9322658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R
    Cancer Res; 1978 Nov; 38(11 Pt 2):4299-304. PubMed ID: 698970
    [No Abstract]   [Full Text] [Related]  

  • 34. Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients.
    Nikolić-Vukosavljević D; Vasiljević N; Branković-Magić M; Polić D
    Neoplasma; 1996; 43(3):163-9. PubMed ID: 8841503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.
    Joensuu H; Isola J; Lundin M; Salminen T; Holli K; Kataja V; Pylkkänen L; Turpeenniemi-Hujanen T; von Smitten K; Lundin J
    Clin Cancer Res; 2003 Mar; 9(3):923-30. PubMed ID: 12631589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic importance of determining steroid hormone receptors in breast tumors].
    Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV; Gershteĭn ES
    Vopr Onkol; 1982; 28(5):82-8. PubMed ID: 7090287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of tumor receptor status in choosing adjuvant therapy for breast cancer patients of reproductive age].
    Samgina AA; Letiagin VP; Kuz'mina ZV
    Vopr Onkol; 1992; 38(7):780-7. PubMed ID: 1300782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estradiol receptor activity in human breast cancer, disease free interval and survival time.
    Heise E; Görlich M
    Anticancer Res; 1982; 2(1-2):33-6. PubMed ID: 7114801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone-receptor assays in breast cancer. A five-year experience.
    Mercer RJ; Lie TH; Rennie GC; Bennett RC; Morgan FJ
    Med J Aust; 1983 Apr; 1(8):365-9. PubMed ID: 6835143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.
    Foekens JA; Schmitt M; van Putten WL; Peters HA; Bontenbal M; Jänicke F; Klijn JG
    Cancer Res; 1992 Nov; 52(21):6101-5. PubMed ID: 1394237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.